Applicable groups for Larotrectinib

Larotrectinib (Larotrectinib) is mainly suitable for the following groups:

1.TRKgene fusion-positive tumor patients: Larotrectinib is a targeted therapy for tumors with TRK (neuronal growth factor receptor) gene fusion-positive tumors. This gene fusion can occur in a variety of cancer types, including but not limited to lung, breast, pancreatic, kidney, and childhood tumors.

2.Tumors that cannot be surgically removed or have metastases: Larotrectinib is often considered for patients with tumors that cannot be surgically removed or have distant metastases, especially if TRK gene fusions have been found in these tumors.

3.Children and adult patients: Larotrectinib can be used in children and adult patients becauseTRKgene fusion may occur in patients of different ages.

4.Patients who have previously received other treatments but whose cancer has not been effectively controlled: Larotrectinib may be a promising treatment option for patients who have previously received other treatments but whose cancer has not been effectively controlled.

It should be emphasized that larotrectinib is only effective for TRK gene fusion-positive tumors. Before larotrectinib is considered, patients usually undergo genetic testing to determine whether TRK gene fusions are present. Treatment plans should be developed by a professional medical team based on the patient's specific circumstances and condition to ensure the best possible outcome.

Patients and doctors should discuss treatment options, including larotrectinib, together to determine whether it is the most appropriate treatment. Before starting larotrectinib, you should learn more about the drug's risks, benefits, and possible side effects, and follow your doctor's recommendations to monitor treatment progress.

Larotrectinib has been launched in China, but it has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.